The genetics of juvenile idiopathic arthritis: Current understanding and future prospects

Rheumatology (United Kingdom)

Volumn 53, Issue 4, 2014, Pages 592-599

  Cobb, Joanna E ^a,b   Hinks, Anne ^a   Thomson, Wendy ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autoimmune disease; Genetics; Juvenile idiopathic arthritis; Predicting drug response

Indexed keywords

HLA DRB1 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; STAT4 PROTEIN;

DRUG RESPONSE; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; OUTCOME ASSESSMENT; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTOIMMUNE DISEASE; GENETICS; JUVENILE IDIOPATHIC ARTHRITIS; PREDICTING DRUG RESPONSE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS;

EID: 84897897401     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket314     Document Type: Review

References (78)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology 2010;49:411-25.
3. Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999;42:2261-8.
4. Prahalad S, O'Brien E, Fraser AM et al. Familial aggregation of juvenile idiopathic arthritis. Arthritis Rheum 2004;50:4022-7.
5. Savolainen A, Saila H, Kotaniemi K et al. Magnitude of the genetic component in juvenile idiopathic arthritis. Ann Rheum Dis 2000;59:1001.
6. Prahalad S, Zeft AS, Pimentel R et al. Quantification of the familial contribution to juvenile idiopathic arthritis. Arthritis Rheum 2010;62:2525-9.
7. Lander ES. The new genomics: global views of biology. Science 1996;274:536-9.
8. Kruglyak L. The road to genome-wide association studies. Nat Rev Genet 2008;9:314-8.
9. Hinks A, Ke X, Barton A et al. Association of the IL2RA/ CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 2009;60:251-7.
10. Hirschhorn JN. Genomewide association studies-illuminating biologic pathways. N Engl J Med 2009;360:1699-701.
11. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011;365:1612-23.
12. Cotsapas C, Voight BF, Rossin E et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011;7:e1002254.
13. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
14. Hinks A, Eyre S, Ke X et al. Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun 2010;11:194-8.
15. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genomewide analyses of type 1 diabetes. Nat Genet 2007;39:857-64.
16. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
17. Hinks A. Genetic polymorphisms in juvenile idiopathic arthritis: effects on disease and therapy. Int J Adv Rheumatol 2010;8:8-15.
18. Moncrieffe H, Hinks A, Ursu S et al. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenet Genomics 2010;20:665-76.
19. Hinks A, Martin P, Flynn E et al. Investigation of type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis. Ann Rheum Dis 2010;69:2169-72.
20. Hinks A, Cobb J, Sudman M et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis 2012;71:1117-21.
21. Hinks A, Barton A, Shephard N et al. Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. Arthritis Rheum 2009;60:258-63.
22. Thompson SD, Marion MC, Sudman M et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 2012;64:2781-91.
23. Thompson SD, Sudman M, Ramos PS et al. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum 2010;62:3265-76.
24. Hollenbach JA, Thompson SD, Bugawan TL et al. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum 2010;62:1781-91.
25. Thomson W, Barrett JH, Donn R et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology 2002;41:1183-9.
26. Macaubas C, Nguyen K, Milojevic D et al. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 2009;5:616-26.
27. Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2008;6:11.
28. Hinks A, Cobb J, Marion M et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013;45:64-9.
29. Prahalad S, Thompson SD, Conneely KN et al. Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope. Arthritis Rheum 2012;64:925-30.
30. Hinks A, Martin P, Flynn E et al. Association of the CCR5 gene with juvenile idiopathic arthritis. Genes Immun 2010;11:584-9.
31. Prahalad S. Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 2006;7:264-8.
32. Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-77.
33. Lee YH, Bae SC, Song GG. Association between the chemokine receptor 5 Δ 32 polymorphism and rheumatoid arthritis: a meta-analysis. Mod Rheumatol 2013;23:304-10.
34. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
35. Cooper JD, Simmonds MJ, Walker NM et al. Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet 2012;21:5202-8.
36. Eyre S, Bowes J, Diogo D et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012;44:1336-40.
37. Juran BD, Hirschfield GM, Invernizzi P et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet 2012;21:5209-21.
38. Liu JZ, Almarri MA, Gaffney DJ et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 2012;44:1137-41.
39. Trynka G, Hunt KA, Bockett NA et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193-201.
40. Tsoi LC, Spain SL, Knight J et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44:1341-8.
41. Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 2008;82:48-56.
42. Pereyra F, Jia X, McLaren PJ et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551-7.
43. Raychaudhuri S, Sandor C, Stahl EA et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44:291-6.
44. Albers HM, Kurreeman FA, Houwing-Duistermaat JJ et al. The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis. Ann Rheum Dis 2008;67:1578-80.
45. Angeles-Han S, Prahalad S. The genetics of juvenile idiopathic arthritis: what is new in 2010? Curr Rheumatol Rep 2010;12:87-93.
46. Sivakumaran S, Agakov F, Theodoratou E et al. Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 2011;89:607-18.
47. Maurano MT, Humbert R, Rynes E et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190-5.
48. Lango AH, Estrada K, Lettre G et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832-8.
49. Yang J, Manolio TA, Pasquale LR et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 2011;43:519-25.
50. Hinks A, Martin P, Flynn E et al. Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis. Arthritis Res Ther 2011;13:R12.
51. Aggarwal A, Srivastava R, Singh S et al. IL1 gene polymorphisms in enthesitis related arthritis category of juvenile idiopathic arthritis (ERA-JIA). Clin Rheumatol 2012;31:607-11.
52. Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment. Int J Inflam 2012;2012:271569.
53. Moller JC, Paul D, Ganser G et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 2010;28:912-8.
54. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
55. Ogilvie EM, Fife MS, Thompson SD et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003;48:3202-6.
56. Lamb R, Thomson W, Ogilvie EM et al. Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2007;56:1286-91.
57. Moorthy LN, Peterson MG, Hassett AL et al. Burden of childhood-onset arthritis. Pediatr Rheumatol Online J 2010;8:20.
58. Oen K, Malleson PN, Cabral DA et al. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology 2005;44:1115-21.
59. Flato B, Hoffmann-Vold AM, Reiff A et al. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum 2006;54:3573-82.
60. Hyrich KL, Lal SD, Foster HE et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology 2010;49:116-22.
61. Oen K, Tucker L, Huber AM et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum 2009;61:1077-86.
62. Berntson L, Andersson GB, Fasth A et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003;30:2275-82.
63. Nordal E, Zak M, Aalto K et al. Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011;63:2809-18.
64. Nordal EB, Zak M, Aalto K et al. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting. Ann Rheum Dis 2012;71:1122-7.
65. Ellis JA, Ponsonby AL, Pezic A et al. CLARITY-ChiLdhood Arthritis Risk Factor Identification STudY. Pediatr Rheumatol Online J 2012;10:37.
66. Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 2003;88:197-200.
67. Becker ML, Leeder JS. Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate. Hum Genomics Proteomics 2010;2010:257120.
68. Ruperto N, Murray KJ, Gerloni V et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191-201.
69. de Rotte MC, Bulatovic M, Heijstek MW et al. ABCB1 and ABCC3 gene polymorphisms are associated with firstyear response to methotrexate in juvenile idiopathic arthritis. J Rheumatol 2012;39:2032-40.
70. Schmeling H, Biber D, Heins S et al. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol 2005;32:1832-6.
71. Albers HM, Wessels JA, van der Straaten RJ et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 2009;61:46-51.
72. Hinks A, Moncrieffe H, Martin P et al. Association of the 5- aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Ann Rheum Dis 2011;70:1395-400.
73. Bulatovic M, Heijstek MW, van Dijkhuizen EH et al. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. Ann Rheum Dis 2012;71:1484-9.
74. Eichler EE, Flint J, Gibson G et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446-50.
75. Orozco G, Hinks A, Eyre S et al. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet 2009;18:2693-9.
76. Visscher PM, Brown MA, McCarthy MI et al. Five years of GWAS discovery. Am J Hum Genet 2012;90:7-24.
77. Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 2012;71:1437-9.
78. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377:2138-49.